2189results about How to "Reduce inhibition" patented technology

The teachings as provided herein relate to a watermark embedded in an image that has the property of being relatively indecipherable under normal light, and yet decipherable under UV light. This fluorescent mark comprises a substrate containing optical brightening agents, and a first colorant mixture pattern printed as an image upon the substrate. The colorant mixture pattern layer has as characteristics a property of strongly suppressing substrate fluorescence, as well as a property of low contrast under normal illumination against the substrate or a second colorant mixture pattern printed in close spatial proximity to the first colorant mixture pattern. The second colorant mixture pattern having a property of providing a differing level of substrate fluorescence suppression from the first such that the resultant image rendered substrate suitably exposed to an ultra-violet light source, will yield a discernable image evident as a fluorescent mark.

This invention relates to antibodies and antigen binding fragments and conjugates containing same, and/or alternative scaffolds, specific for LSR molecules, which are suitable drugs for immunotherapy and treatment of specific cancer.

A driver circuit includes a circuit 200, a transistor 101_—1, and a transistor 101_—2. A signal is selectively input from the circuit 200 to a gate of the transistor 101_—1 and the transistor 101_—2, so that the transistor 1011 and the transistor 101_—2 are controlled to be on or off. The transistor 101_—1 and the transistor 101_—2 are turned on or off; thus, the wiring 112 and the wiring 111 become conducting or non-conducting.

The invention relates to a system and a method for eliminating common station site interference. The system comprises a first coupler, a transmission unit, an adjustment unit, an offset unit and a detection control unit, wherein the first coupler is used for extracting a signal transmitted by an interference base station as an interference offset signal, and coupling the interference offset signal to the transmission unit; the transmission unit is used for transmitting the interference offset signal to the adjustment unit; the adjustment unit is used for carrying out time delay, amplitude andphase adjustment of the interference offset signal to ensure that the interference offset signal and an interference signal received by a receiver from the interference base station through a wireless path have identical amplitudes and 180-degree phase difference; the offset unit is used for adding the interference offset signal adjusted by the adjustment unit to the interference signal received by the receiver from the interference base station, thereby offsetting the interference signal from the interference base station; and the detection control unit is used for controlling the adjustmentunit to carry out time delay, amplitude and phase adjustment of the interference offset signal according to the interference signal received by the receiver from the interference base station.

The present invention relates to improved methods of treating fibrotic or fibroproliferative disorders. Conjoint therapies are provided comprising the combination of one or more fibrocyte suppressors and one or more profibrotic factor antagonists or anti-fibrotic agents.

Various bispecific antibodies that specifically bind to both blood coagulation factor IX/activated blood coagulation factor IX and blood coagulation factor X and functionally substitute for the cofactor function of blood coagulation factor VIII, that is, the function to promote activation of blood coagulation factor X by activated blood coagulation factor IX, were produced. From these antibodies, multispecific antigen-binding molecules having a high activity of functionally substituting for blood coagulation factor VIII were successfully discovered.

This invention provides methods and compositions for the detection, diagnosis and treatment of amyloid-associated diseases, in particular, diseases comprising deposition of amyloid assemblies, fibrils, filaments, tangles, or plaques. A preferred composition comprises monoclonal antibodies that specifically bind amyloid proteins, peptides or fragments and change the conformation.

Composition and methods of using melanin, or melanin-promoting compounds, for inhibiting angiogenesis to treat angiogenesis-dependent diseases, such as macular degeneration and cancer.

The invention discloses a device and a method for denitrification of single stage autotroph in low-cellulose nitrate (CN) high-ammonia nitrogen waste water. The device comprises a raw water tank, a water inlet pump, a reactor, a secondary sedimentation tank and a sludge reflux pump, wherein overcurrent holes are arranged in the water flow direction of the reactor in an up-and-down alternative form and connected with various grid chambers, an anoxic zone grid chamber is arranged at the front end of the reactor, and an aerobic zone grid chamber is arranged at the back end of the reactor; the anoxic zone grid chamber is provided with a stirrer and an agitator blade; the aerobic zone grid chamber is provided with the stirrer, the agitator blade, an aeration riser pipe and an intermediate perforated clapboard; and the aeration riser pipe is internally provided with an aeration head, and sponge filling material is filled below the intermediate perforated clapboard, wherein filling ratio is 30-50%. In the method, shortcut nitrification is achieved above the aerobic zone through low dissolved oxygen (DO is 0.5 <-1>mg/L) and free ammonia (FA) inhibition so that ammonia nitrogen is converted to nitrite nitrogen; and anoxicammoxidation biomembrane acts on the lower part of the aerobic zone, the nitrite nitrogen and ammonia nitrogen are converted to nitrogen, thereby achieving denitrification of autotroph. The method has the advantages of low oxygen consumption, less sludge output and no extra carbon source.

A method for treating municipal solid waste and other waste is provided which comprises: introducing said waste into a rotary autoclave which is downwardly inclined towards its discharge end and has a door at the discharge end; and injecting steam through said door into said autoclave to treat the load. A method is also provided for treating waste, comprising steam autoclaving the waste, anaerobically digesting an organic-rich fraction of the autoclaved waste, recovering methane-containing gas from anaerobic digestion, internally combusting the methane-containing gas to generate power and exhaust gas, and generating steam for autoclaving using the waste heat. A plant for treating the waste may comprise at least one autoclave for steam treating the waste, at least one anaerobic digestion tank for digesting an organic-rich fraction of the autoclaved waste, a recovery system for recovering methane-containing gas from the or each digestion tank, at least one internal combustion engine for combusting the methane-containing gas and generating power, and a steam generator fed with combustion gas from the internal combustion engine for generating and accumulating steam for supply to said at least one autoclave. Also provided is a method of treating waste material in a rotary autoclave, which comprises: loading the waste material into a top opening of the autoclave whilst rotating the autoclave in a first direction in which screw flights within the autoclave convey the waste forwardly along a downwardly inclined body of the autoclave towards a base of the autoclave; rotating the autoclave in a second direction opposite to the first direction so as to establish a circulation of the loaded material between the upper and lower ends of the autoclave to facilitate vacuum and/or steam treatment thereof; and monitoring the load imparted by the autoclave adjacent upper and lower ends thereof during the reverse rotation, increase of the load adjacent the upper end of the autoclave providing an indication of effective load circulation. A door structure for a commercial-scale autoclave based on a castellated door and a locking ring with lock blocks of inwardly facing U-structure is also provided.

Production of fermentation products, such as ethanol and lactic acid in biofilm reactors by microorganisms immobilised on sterilised granular sludge.

The invention refers to a preparation method of ginseng polysaccharide. The method includes the following step: extract it from the ginseng or the marc of the ginseng decocted, filtrate, concentrate and deposit the extracting solution, get the precipitate after centrifugence and dry it with low temperature to get the crude product of ginseng polysaccharide. We get the polysaccharide product after the ginseng polysaccharide goes through the boiling, depositing, filtration, trash extraction, frost thawing, getting rid of the protein and getting the supernatant and the supernatant passes through the concentration with low pressure and drying with low temperature. We can make it into all kinds of forms of prepared drugs after the ginseng polysaccharide passes through the experiments in pharmaceutics. The invention effectively increases the quality of the ginseng polysaccharide injection, fully exerts the immunoloregulation function of the ginseng polysaccharide, increases the anti tumor effect of chemotherapy medicament and is used to reduce the side effect caused by the knubbly radiotherapy and chemotherapy as well as adjuvant for curing the tumor.